Feng Sun

Associate Professor
sunfeng@bjmu.edu.cn
Xueyuan Road 38, Haidian District, Beijing, China
Peking University

Personal profile

Education and Working Experience

Dr. Sun, the deputy director of Peking University Center for Evidence Based Medicine and Clinical Research, received her PhD in Epidemiology and Health Statistics from the School of Public Health, Peking University in 2009 on pharmaco-epidemiology and evidence-based medicine, then she finished the post-doctoral research in Clinical Pharmacy and Pharmaco-epidemiology in School of Pharmacy, Peking University from 2010 to 2012. Afterwards, she worked as Visiting Associate Professor of Department of Population Medicine, Harvard Medical School from 2017 to 2018.External master/doctoral supervisor of Pharmaceutical and Medical Device Regulatory Scientific Research Base of State Food and Drug Administration in Hainan Real World Data Research Institute.

Dr. Sun has led 3 research projects funded by the National Natural Science Foundation of China, 1 research sub-project from National Key R&D Program of China (2021YFC2301601), more than 10 research projects funded by national ministries, and participated more than 20 studies in chronic disease epidemiology, pharmaco-epidemiology and evidence-based medicine. As the chief editor or deputy chief-editor, she undertook the organization and writing of 7 academic books, and published more than 130 articles in Chinese and English as the first or corresponding author. In 2013, Dr. Sun won the title of "Rising Star" of Asia-Pacific Pharmaco-epidemiology Association, and in 2018 won the ATS Foundation MECOR Award, and being the tutor of an outstanding winner project in the Wusi Youth Academic Prize in the PKU in 2019. In 2021, she won the Teaching Excellence Award of Peking University Health Science Center and the Teaching Fund of Peking University Zhongwai Medicine. Also, in 2021, she was selected as a key member of the Traditional Chinese Medicine Inheritance and Innovation Team of the State Administration of Traditional Chinese Medicine.

Academic Titles

At present, Dr. Sun is the vice director of the Committee of Specialty Boards of Evidence-Based Medicine in Chinese Medical Doctors’ Association, vice director of the Youth Committee of Clinical Epidemiology and Evidence-Based Medicine Branch of Beijing Medical Association, vice leader of the Youth Committee of Pharmaco-epidemiology of Chinese Pharmaco-epidemiology Society, member of the Standing Committee of China International Exchange and Promotive Association for Medical and Health Care, vice leader of Methodology Group of Evidence-Based Medicine branch of China Preventive Medicine Association, member of the sixth Clinical Toxicology Committee of Chinese Society of Toxicology, member of the Standing Committee of the Compilation Committee of Evidence-Based Medicine Textbooks for colleges and universities in China (academic secretary), expert of Beijing Municipal Commission of Science and Technology in Medical and Health Field, member of the Technical Working Group on National Immunization Program, member of academic Committee of Key Laboratory of Pharmacovigilance Technology Research and Evaluation, National Medical Products Administration. Member of the Expert Committee on test question-bank systems Development of National Medical Examination Center; External expert of Medical Device Technical Evaluation Center, National Medical Products Administration.

Dr. Sun is currently the co-director of Cochrane Geographic Group Host Institution of Peking University, and also is the group leader of "advanced methodology of systematic reviews and meta-analysis (AM-SRMA)" in Cochrane China Network. And also, she is the vice director of Clinical Efficacy Evaluation Professional Committee of the World Federation of Chinese Medicine Societies (WFCMS), the member of ISPE and APCE in the field of pharmacoepidemiology.

Dr. Sun is also the editor or corresponding editor of the Chinese Medical Journal (English version), Clinical Trials (Chinese version), Chinese Journal of Epidemiology, the Chinese Journal of Evidence-Based Medicine, Chinese Journal of Evidence-based Cardiovascular Medicine, Chinese Journal of Evidence-based Pediatrics and the journal Pharmacoepidemiology.

Main research directions

Pharmaco-epidemiology; Evidence-Based Medicine; Theoretical methods and applications of real-world data research

ResearchGate: https://www.researchgate.net/profile/Feng-Sun-25

ORCID: https://orcid.org/0000-0003-4334-6805

Dr. Sun’s interests are in the field of pharmacoepidemiology, evidence-based medicine and Clinical Epidemiology, in particular the use of new methodology to conduct Comparative Effectiveness Research. She has published widely in the areas of cardiovascular, endocrine, cancer and neurodegenerative disease epidemiology and medication safety. Now she is working on several potential new projects for integrating different data resources by building an innovational collaborative model, such as to combine randomized controlled trials, literature data and real-world data from medical platforms around the world.

Representative scientific research projects

2021.01-2024.12. Demonstration and its application on calibrating estimates of real-world treatment effectiveness in patients with type 2 diabetes: Maximizing the applicability of clinical trials. Founded by the National Natural Science Foundation of China (NSFC No. 72074011).
2021.11-2024.12. Appropriate Methods and Real-World Surveillance Strategies for active vaccine Safety Monitoring. Founded by National Key R&D Program of China Project sub-Project (No. 2021YFC2301601).
2017.01-2020.12. Developing methodological guidance for evidence-based evaluation of cancer screening programs in the Chinese setting and its application. Founded by the National Natural Science Foundation of China (NSFC, No. 71673003).
2014.01-2016.12. Quality Evaluation of Multiple Treatments Meta-analysis and Study on Several Pivotal Statistical Methods. Founded by the National Natural Science Foundation of China (NSFC, No. 81302508).
2022.10-2023.06. Evidence-based evaluation of the effectiveness and safety of pelvic floor repair systems. Founded by the Adverse Reaction Monitoring Center of Beijing.
2022.09-2023.12. Technical support and literature study of vaccine safety active surveillance research. Founded by Chinese Center for Disease Control and Prevention;
2022.03-2028.12. Impact of HPV Vaccination on HPV Infection and Cervical Related Disease Burden in Real-World Settings (HPV-RWS): A Prospective Cohort. Founded by Company.
2021.08-2023.08. Entrusted by Drug Evaluation Center of National Medical Products Administration [No.10]: Research on the vigilance technology and methods of drugs and medical devices. Founded by the second batch of key projects of China Drug Regulatory Science Action Plan (No. [2021]37-10).
2021.11-2022.12. Literature study on vaccine safety and construction of national Active Vaccine Safety Monitoring Platform. Founded by Chinese Center for Disease Control and Prevention:
2021.11-2022.12.: Research on the guiding principles and method validation of multi-source Electronic Diagnosis and Treatment Data Convergence analysis. Founded by Chinese Society of Toxicology clinical Toxicology Specialty (2021) Orientation entrusted project (CST2021CT102).

10 representative papers

1. Sun Feng (Chief Editor), Yang Zhirong, Zeng Xiantao and Zhan Siyan. Interpretation of Medical research reporting guidelines, Beijing, Peking University Medical Press, 2015. (ISNB:978-7-5659-1170-5).

2. Sun Feng (Chief Editor), Zhan Siyan (Chief Reviewer). The Common Statistical Analysis Methods in Clinical Research - SPSS Examples Tutorial. Beijing, Science Press, 2020. (ISNB: 9787030660879)

3. Zhan Siyan (Chief Editor), Wang Congxia, Sun Feng (Associate Editor). Systematic Review and Meta-Analysis, People's Medical Publishing House, 2019 (ISBN: 978-7-117-29045-6)

4. Chen Yaolong (Chief Editor), Sun Feng, Du Liang (Associate Editor). The Application of GRADE in Systematic Evaluation and Practical Guidance. China Union Medical College Press. 2021 (ISBN: 9787567917231)

5. Baoqi Zeng, Le Gao, Qingqing Yang, Hao Jia, and Feng Sun*. Automated insulin delivery systems in children and adolescents with type 1 diabetes: a systematic review and meta-analysis of outpatient randomised controlled trials. Diabetes Care, 2023;46(12):2300-2307. (IF= 17.152, Q1)

6. Qingqing Yang; Zhirong Yang; Xianming Cai; Houyu Zhao; Jinzhu Jia*; Feng Sun*. Advances in Methodologies of Negative Controls: A Scoping Review. Journal of Clinical Epidemiology. 2023, doi: https://doi.org/10.1016/j.jclinepi.2023.111228 (IF= 7.2, Q1)

7. Yuan K#, Sun F#, Zhang Y, Du Y, Wu L, Ge Y, Zhang Z, Cao W, Sun S. Ambient Temperature and Major Structural Anomalies: A Retrospective Study of Over 2 Million Newborns. Science of The Total Environment, 2023. （IF= 10.753, Q1）

8. Yuan K#, Sun F#, Zhang Y, Du Y, Wu L, Ge Y, Zhang Z, Cao W, Sun S. Maternal exposure to ozone and risk of gestational hypertension and eclampsia in the United States. Science of The Total Environment, 2023:162292. （IF= 10.753, Q1）

9. Zeng B, Gao L, Zhou Q, Yu K*, Sun F*. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med, 2022; 20(1):200. (IF= 11.806, Q1)

10. Sun S, Yang Q, Zhou Q, Cao W, Yu S, Zhan S, Sun F*. Long-term exposure to fine particulate matter and non-alcoholic fatty liver disease: a prospective cohort study. Gut,2022;71(2):443-445. (IF= 31.795, Q1)